Valeria Studer

2.4k total citations
40 papers, 1.9k citations indexed

About

Valeria Studer is a scholar working on Pathology and Forensic Medicine, Neurology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Valeria Studer has authored 40 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Pathology and Forensic Medicine, 17 papers in Neurology and 9 papers in Cellular and Molecular Neuroscience. Recurrent topics in Valeria Studer's work include Multiple Sclerosis Research Studies (30 papers), Neuroinflammation and Neurodegeneration Mechanisms (14 papers) and Neuroscience and Neuropharmacology Research (8 papers). Valeria Studer is often cited by papers focused on Multiple Sclerosis Research Studies (30 papers), Neuroinflammation and Neurodegeneration Mechanisms (14 papers) and Neuroscience and Neuropharmacology Research (8 papers). Valeria Studer collaborates with scholars based in Italy, United States and Germany. Valeria Studer's co-authors include Silvia Rossi, Diego Centonze, Caterina Motta, Giorgio Bernardi, Gianvito Martino, Valentina De Chiara, Roberto Furlan, Francesca Barbieri, Alessandra Musella and Fabio Buttari and has published in prestigious journals such as Journal of Neuroscience, PLoS ONE and Neurology.

In The Last Decade

Valeria Studer

40 papers receiving 1.8k citations

Peers

Valeria Studer
Valeria Studer
Citations per year, relative to Valeria Studer Valeria Studer (= 1×) peers Diego Fresegna

Countries citing papers authored by Valeria Studer

Since Specialization
Citations

This map shows the geographic impact of Valeria Studer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Valeria Studer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Valeria Studer more than expected).

Fields of papers citing papers by Valeria Studer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Valeria Studer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Valeria Studer. The network helps show where Valeria Studer may publish in the future.

Co-authorship network of co-authors of Valeria Studer

This figure shows the co-authorship network connecting the top 25 collaborators of Valeria Studer. A scholar is included among the top collaborators of Valeria Studer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Valeria Studer. Valeria Studer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Studer, Valeria, Laura Brambilla, Chiara Zecca, et al.. (2021). Immune Soluble Factors in the Cerebrospinal Fluid of Progressive Multiple Sclerosis Patients Segregate Into Two Groups. Frontiers in Immunology. 12. 633167–633167. 12 indexed citations
2.
Studer, Valeria, et al.. (2017). Treadmill Training with Cues and Feedback Improves Gait in People with More Advanced Parkinson’s Disease. Journal of Parkinson s Disease. 7(4). 729–739. 13 indexed citations
3.
Rossi, Stefano, Valeria Studer, Gessica Vasco, et al.. (2017). Quantification of postural stability in minimally disabled multiple sclerosis patients by means of dynamic posturography: an observational study. Journal of NeuroEngineering and Rehabilitation. 14(1). 4–4. 22 indexed citations
4.
Motta, Caterina, Eduardo Palermo, Valeria Studer, et al.. (2016). Disability and Fatigue Can Be Objectively Measured in Multiple Sclerosis. PLoS ONE. 11(2). e0148997–e0148997. 24 indexed citations
5.
Sallustio, Fabrizio & Valeria Studer. (2016). Targeting New Pharmacological Approaches for Alzheimer's Disease: Potential for Statins and Phosphodiesterase Inhibitors. CNS & Neurological Disorders - Drug Targets. 15(6). 647–659. 12 indexed citations
6.
Rossi, Silvia, Valeria Studer, Caterina Motta, et al.. (2014). Cerebrospinal fluid detection of interleukin-1β in phase of remission predicts disease progression in multiple sclerosis. Journal of Neuroinflammation. 11(1). 32–32. 69 indexed citations
7.
Mori, Francesco, Carolina Gabri Nicoletti, Silvia Rossi, et al.. (2014). Growth Factors and Synaptic Plasticity in Relapsing–Remitting Multiple Sclerosis. NeuroMolecular Medicine. 16(2). 490–498. 15 indexed citations
8.
Rossi, Silvia, Caterina Motta, Valeria Studer, et al.. (2014). Treatment Options to Reduce Disease Activity After Natalizumab: Paradoxical Effects of Corticosteroids. CNS Neuroscience & Therapeutics. 20(8). 748–753. 7 indexed citations
9.
Rossi, Silvia, Marco Bozzali, Monica Bari, et al.. (2013). Association between a Genetic Variant of Type-1 Cannabinoid Receptor and Inflammatory Neurodegeneration in Multiple Sclerosis. PLoS ONE. 8(12). e82848–e82848. 20 indexed citations
10.
Gentile, Antonietta, Silvia Rossi, Valeria Studer, et al.. (2013). Glatiramer Acetate Protects Against Inflammatory Synaptopathy in Experimental Autoimmune Encephalomyelitis. Journal of Neuroimmune Pharmacology. 8(3). 651–663. 21 indexed citations
11.
Mori, Francesco, Silvia Rossi, Sonia Piccinin, et al.. (2013). Synaptic Plasticity and PDGF Signaling Defects Underlie Clinical Progression in Multiple Sclerosis. Journal of Neuroscience. 33(49). 19112–19119. 71 indexed citations
12.
Musella, Alessandra, Georgia Mandolesi, Antonietta Gentile, et al.. (2013). Cladribine interferes with IL-1β synaptic effects in experimental multiple sclerosis. Journal of Neuroimmunology. 264(1-2). 8–13. 24 indexed citations
13.
Vitale, Chiara, Caterina Motta, Silvia Rossi, et al.. (2013). Interleukin-1β alters the sensitivity of cannabinoid CB1 receptors controlling glutamate transmission in the striatum. Neuroscience. 250. 232–239. 34 indexed citations
14.
Rossi, Silvia, Lucia Sacchetti, Francesco Napolitano, et al.. (2012). Interleukin-1β Causes Anxiety by Interacting with the Endocannabinoid System. Journal of Neuroscience. 32(40). 13896–13905. 93 indexed citations
15.
Rossi, Silvia, Caterina Motta, Valeria Studer, et al.. (2012). A genetic variant of the anti-apoptotic protein Akt predicts natalizumab-induced lymphocytosis and post-natalizumab multiple sclerosis reactivation. Multiple Sclerosis Journal. 19(1). 59–68. 18 indexed citations
16.
Rossi, Silvia, Roberto Furlan, Valentina De Chiara, et al.. (2011). Cannabinoid CB1 receptors regulate neuronal TNF-α effects in experimental autoimmune encephalomyelitis. Brain Behavior and Immunity. 25(6). 1242–1248. 63 indexed citations
17.
Rossi, Silvia, Roberto Furlan, Valentina De Chiara, et al.. (2011). Interleukin‐1β causes synaptic hyperexcitability in multiple sclerosis. Annals of Neurology. 71(1). 76–83. 176 indexed citations
18.
Rossi, Silvia, Temistocle Lo Giudice, Chiara Vitale, et al.. (2011). Oral fingolimod rescues the functional deficits of synapses in experimental autoimmune encephalomyelitis. British Journal of Pharmacology. 165(4). 861–869. 61 indexed citations
19.
Musumeci, Gabriele, Giorgio Grasselli, Silvia Rossi, et al.. (2011). Transient receptor potential vanilloid 1 channels modulate the synaptic effects of TNF-α and of IL-1β in experimental autoimmune encephalomyelitis. Neurobiology of Disease. 43(3). 669–677. 57 indexed citations
20.
Castelli, Maura, Mauro Federici, Silvia Rossi, et al.. (2011). Loss of striatal cannabinoid CB1 receptor function in attention‐deficit / hyperactivity disorder mice with point‐mutation of the dopamine transporter. European Journal of Neuroscience. 34(9). 1369–1377. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026